US · BCAT
BlackRock Capital Allocation Trust
- Sector
- Financial Services · Asset Management
- Headquarters
- New York City, NY 10055
Price · as of 2024-12-31
$15.20
Market cap 1.59B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $31.07 | +104.41% |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $10.99 | ||||
| 2021 | $8.98 | $22.42 | |||
| 2022 | $8.77 | $72.74 | |||
| 2023 | $10.56 | $32.84 | |||
| 2024 | $12.18 | $31.07 |
AI valuation
Our deep-learning model estimates BlackRock Capital Allocation Trust's (BCAT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $31.07
- Current price
- $15.20
- AI upside
- +104.41%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| BCAT | BlackRock Capital Allocat… | $15.20 | 1.59B | +104% | — | — | — | 6.66 | 0.75 | 6.55 | — | 236.94 | 0.75 | 100.00% | 98.35% | 98.35% | 10.88% | 10.92% | 9.79% | 0.00 | 138.47 | — | — | — | 281.00% | -446.00% | 9572.00% | 27.43% | — | 19.93% | 21.75% | 144.80% | 25.26% | 6.62 | 3.63 | 6.51 | 4.26 |
| BDJ | BlackRock Enhanced Equity… | $9.67 | 1.71B | +165% | -17% | -68% | — | 8.55 | 0.88 | 30.09 | — | 57.70 | 0.88 | 100.00% | 68.30% | 352.03% | 10.18% | 2.00% | 10.01% | 0.00 | 7848.88 | 2.88 | 3.01 | — | 1481.00% | -6910.00% | 5166.00% | 14.88% | 12.95 | 13.13% | 8.89% | 76.00% | 14.89% | 42.60 | 6.50 | 29.10 | 52.65 |
| BMEZ | BlackRock Health Sciences… | $15.03 | 1.52B | +234% | +34,290% | +74% | +2,178% | 7.83 | 0.24 | 7.63 | 6.69 | 34.16 | 0.24 | 100.00% | 3.85% | 97.44% | 3.46% | 0.14% | 3.42% | 0.00 | 11886.87 | — | — | 0.00 | 2292.00% | 19379.00% | 10463.00% | 35.69% | — | 9.85% | 19.57% | 153.20% | 35.69% | 169.68 | 2.40 | 6.54 | 18.04 |
| BST | BlackRock Science and Tec… | $40.19 | 1.4B | +395% | -28% | -14% | +7,564% | 3.96 | 0.78 | 3.93 | 3.96 | — | 0.78 | 100.00% | 99.31% | 99.31% | 21.18% | 21.18% | 20.87% | 0.00 | 77771.91 | — | — | 0.00 | -892.00% | 40115.00% | -37398.00% | 8.73% | — | 7.32% | 9.50% | 37.60% | 10.06% | 3.96 | 11.45 | 3.93 | 49.69 |
| BTT | Blackrock Municipal 2030 … | $22.94 | 1.47B | +18% | -38% | -16% | -77% | 26.22 | 0.92 | 17.30 | — | 132.97 | 0.92 | 100.00% | 80.19% | 65.99% | 3.50% | 2.82% | 2.27% | 0.54 | — | 0.23 | 0.42 | — | 1972.00% | -205.00% | -5598.00% | 4.24% | 0.61 | 2.58% | 2.74% | 72.00% | 5.22% | 33.87 | 37.05 | 27.16 | 1.09 |
| ECAT | BlackRock ESG Capital All… | $15.14 | 1.5B | +98% | — | — | — | 5.62 | 0.77 | 5.52 | — | — | 0.77 | 100.00% | 98.36% | 98.36% | 13.43% | 13.46% | 12.42% | 0.00 | 180898.81 | — | — | — | -1856.00% | -1777.00% | 10436.00% | 25.05% | — | 18.93% | 21.34% | 119.90% | 24.79% | 5.60 | 3.98 | 5.51 | 6.01 |
About BlackRock Capital Allocation Trust
BlackRock Capital Allocation Term Trust is a newly organized, non-diversified, closed-end management investment company with no operating history. Its investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust is headquartered in Wilmington, DE.
- CEO
- John M. Perlowski
- Employees
- 0
- Beta
- 0.76
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $15.20) − 1 = — (DCF, example).